Is 1,5-Anhydroglucitol in saliva a noninvasive marker of short-term glycemic control?
Clinical studies have already established 1,5-AG in blood as a reliable marker of short-term glycemic control. Our study suggests that 1,5-AG in saliva can be used in national screening programs for undiagnosed diabetes, which are of particular interest for Middle Eastern countries with young populations and exceptionally high diabetes rates.
Women with hypertension had lower levels of IgG anti-oxidized LDL antibodies than normotensive women.